Effects of sufentanil in combination with dexmedetomidine for patient-controlled intravenous analgesia after renal transplantation
Background/Aim. Nowadays, the most convenient analgesic method is patient-controlled intravenous injection of one or more adjuvant drugs. The aim of our study was to evaluate the effects of sufentanil plus dexmedetomidine for patient-controlled intravenous analgesia (PCIA) after renal transplantatio...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
2025-01-01
|
| Series: | Vojnosanitetski Pregled |
| Subjects: | |
| Online Access: | https://doiserbia.nb.rs/img/doi/0042-8450/2025/0042-84502400057M.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850248864438681600 |
|---|---|
| author | Ma Jun Yang Yawen Sun Linhao Wu Tingting |
| author_facet | Ma Jun Yang Yawen Sun Linhao Wu Tingting |
| author_sort | Ma Jun |
| collection | DOAJ |
| description | Background/Aim. Nowadays, the most convenient analgesic method is patient-controlled intravenous injection of one or more adjuvant drugs. The aim of our study was to evaluate the effects of sufentanil plus dexmedetomidine for patient-controlled intravenous analgesia (PCIA) after renal transplantation. Methods. Seventy-eight patients receiving living-related renal transplantation under general anesthesia were selected. Radioisotope scanning was performed, and the single glomerular filtration rate of the unilateral kidney was ≥ 40 mL/min/1.73 m2. The control group (CG) and observation group (OG) (39 patients in each group) were analgesic with sufentanil and sufentanil plus dexmedetomidine, respectively. When the Visual Analogue Scale (VAS) score exceeded 4 points, 0.05 mg/kg oxycodone was intra-venously injected for remedial analgesia. Plasma levels of endothelin, urea nitrogen, and creatinine were measured by radioimmunoassay. Heart rate (HR), mean arterial pressure, oxygen saturation, VAS score, and sedation score were recorded before anesthesia and after surgery. Analgesic remediation rate, number of effectively pressing the PCIA pump, and incidence rate of adverse reactions within 48 hrs after surgery were recorded. Results. HR of OG was significantly lower than that of CG 6 and 12 hrs after surgery (p < 0.05). VAS score of OG was lower than that of CG 6, 12, and 24 hrs after surgery (p < 0.05). OG had a lower postoperative remedial rate, number of effectively pressing the PCIA pump, and incidence rates of nausea and vomiting (p < 0.05) compared to CG. Endothelin, urea nitrogen, and creatinine levels significantly decreased after surgery com-pared with those before anesthesia (p < 0.05). The levels of OG were lower than those of CG at each time point after surgery (p < 0.05). Conclusion. Sufentanil plus dexmedetomidine can be safely and effectively used for PCIA after renal transplantation, with superior outcomes to those of sufentanil alone. |
| format | Article |
| id | doaj-art-88a902acf1734fb0bcc75c594e4775cb |
| institution | OA Journals |
| issn | 0042-8450 2406-0720 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade |
| record_format | Article |
| series | Vojnosanitetski Pregled |
| spelling | doaj-art-88a902acf1734fb0bcc75c594e4775cb2025-08-20T01:58:37ZengMinistry of Defence of the Republic of Serbia, University of Defence, BelgradeVojnosanitetski Pregled0042-84502406-07202025-01-0182314014510.2298/VSP231103057M0042-84502400057MEffects of sufentanil in combination with dexmedetomidine for patient-controlled intravenous analgesia after renal transplantationMa Jun0Yang Yawen1Sun Linhao2Wu Tingting3Wuhan Wuchang Hospital, Department of Anesthesiology, Wuhan, ChinaSoochow University, First Affiliated Hospital, Department of Anesthesiology, Suzhou, ChinaSoochow University, First Affiliated Hospital, Department of Anesthesiology, Suzhou, ChinaSoochow University, First Affiliated Hospital, Department of Anesthesiology, Suzhou, ChinaBackground/Aim. Nowadays, the most convenient analgesic method is patient-controlled intravenous injection of one or more adjuvant drugs. The aim of our study was to evaluate the effects of sufentanil plus dexmedetomidine for patient-controlled intravenous analgesia (PCIA) after renal transplantation. Methods. Seventy-eight patients receiving living-related renal transplantation under general anesthesia were selected. Radioisotope scanning was performed, and the single glomerular filtration rate of the unilateral kidney was ≥ 40 mL/min/1.73 m2. The control group (CG) and observation group (OG) (39 patients in each group) were analgesic with sufentanil and sufentanil plus dexmedetomidine, respectively. When the Visual Analogue Scale (VAS) score exceeded 4 points, 0.05 mg/kg oxycodone was intra-venously injected for remedial analgesia. Plasma levels of endothelin, urea nitrogen, and creatinine were measured by radioimmunoassay. Heart rate (HR), mean arterial pressure, oxygen saturation, VAS score, and sedation score were recorded before anesthesia and after surgery. Analgesic remediation rate, number of effectively pressing the PCIA pump, and incidence rate of adverse reactions within 48 hrs after surgery were recorded. Results. HR of OG was significantly lower than that of CG 6 and 12 hrs after surgery (p < 0.05). VAS score of OG was lower than that of CG 6, 12, and 24 hrs after surgery (p < 0.05). OG had a lower postoperative remedial rate, number of effectively pressing the PCIA pump, and incidence rates of nausea and vomiting (p < 0.05) compared to CG. Endothelin, urea nitrogen, and creatinine levels significantly decreased after surgery com-pared with those before anesthesia (p < 0.05). The levels of OG were lower than those of CG at each time point after surgery (p < 0.05). Conclusion. Sufentanil plus dexmedetomidine can be safely and effectively used for PCIA after renal transplantation, with superior outcomes to those of sufentanil alone.https://doiserbia.nb.rs/img/doi/0042-8450/2025/0042-84502400057M.pdfanalgesiaanalgesiapatient-controlledanesthesiaintravenouskidney transplantationpostoperative period |
| spellingShingle | Ma Jun Yang Yawen Sun Linhao Wu Tingting Effects of sufentanil in combination with dexmedetomidine for patient-controlled intravenous analgesia after renal transplantation Vojnosanitetski Pregled analgesia analgesia patient-controlled anesthesia intravenous kidney transplantation postoperative period |
| title | Effects of sufentanil in combination with dexmedetomidine for patient-controlled intravenous analgesia after renal transplantation |
| title_full | Effects of sufentanil in combination with dexmedetomidine for patient-controlled intravenous analgesia after renal transplantation |
| title_fullStr | Effects of sufentanil in combination with dexmedetomidine for patient-controlled intravenous analgesia after renal transplantation |
| title_full_unstemmed | Effects of sufentanil in combination with dexmedetomidine for patient-controlled intravenous analgesia after renal transplantation |
| title_short | Effects of sufentanil in combination with dexmedetomidine for patient-controlled intravenous analgesia after renal transplantation |
| title_sort | effects of sufentanil in combination with dexmedetomidine for patient controlled intravenous analgesia after renal transplantation |
| topic | analgesia analgesia patient-controlled anesthesia intravenous kidney transplantation postoperative period |
| url | https://doiserbia.nb.rs/img/doi/0042-8450/2025/0042-84502400057M.pdf |
| work_keys_str_mv | AT majun effectsofsufentanilincombinationwithdexmedetomidineforpatientcontrolledintravenousanalgesiaafterrenaltransplantation AT yangyawen effectsofsufentanilincombinationwithdexmedetomidineforpatientcontrolledintravenousanalgesiaafterrenaltransplantation AT sunlinhao effectsofsufentanilincombinationwithdexmedetomidineforpatientcontrolledintravenousanalgesiaafterrenaltransplantation AT wutingting effectsofsufentanilincombinationwithdexmedetomidineforpatientcontrolledintravenousanalgesiaafterrenaltransplantation |